Holen Sie sich die Stockscreener-App
94.78
0.00%
0.00
Handel nachbörslich:
96.21
1.43
+1.51%
Schlusskurs vom Vortag:
$94.78
Offen:
$94.75
24-Stunden-Volumen:
1.57M
Relative Volume:
0.71
Marktkapitalisierung:
$18.35B
Einnahmen:
$8.23B
Nettoeinkommen (Verlust:
$705.10M
KGV:
26.72
EPS:
3.5467
Netto-Cashflow:
$1.12B
1W Leistung:
+1.78%
1M Leistung:
+2.44%
6M Leistung:
-7.01%
1J Leistung:
-3.21%
1-Tages-Spanne:
$94.59
$96.56
1-Wochen-Bereich:
$92.24
$97.81
52-Wochen-Spanne:
$84.59
$108.29
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
94.78 | 18.35B | 8.23B | 705.10M | 1.12B | 3.5467 |
ABT
Abbott Laboratories
|
96.81 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
343.32 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.19 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.23 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.99 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-23 | Herabstufung | BTIG Research | Buy → Neutral |
| 2026-02-20 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-09 | Herabstufung | Goldman | Neutral → Sell |
| 2026-01-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Hochstufung | Roth Capital | Neutral → Buy |
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Zimmer Biomet Receives FDA Clearance for Expanded Reverse Shoulder Systems - Orthopedics This Week
Zimmer Biomet Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Leerink Sees Limited Near-Term Upside for Zimmer Biomet Holdings, Inc. (ZBH) Ahead of 2027 Catalysts - Insider Monkey
Thomasville National Bank Sells 102,815 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Short Interest Up 24.8% in March - MarketBeat
Ambulatory Surgical Equipment Market to Reach USD 14.58 Billion, Rising at 7.85% by 2035 - GlobeNewswire Inc.
Border to Coast Pensions Partnership Ltd Acquires 35,159 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
ZBH Technical Analysis | Trend, Signals & Chart Patterns | ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - ChartMill
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Shareholder Vote Puts Board Leadership And Valuation In Focus - simplywall.st
Zimmer Biomet stock (US98956P1021): Is its knee implant dominance strong enough to unlock new upside - AD HOC NEWS
Leerink Partners initiates coverage of Zimmer Biomet Holdings (ZBH) with market perform recommendation - MSN
Zimmer Biomet stock (US98956P1021): Is supply chain resilience now the real test for medtech growth? - AD HOC NEWS
Leerink Partners Begins Coverage on Zimmer Biomet (NYSE:ZBH) - MarketBeat
Leerink initiates Zimmer Biomet stock coverage with Market Perform By Investing.com - Investing.com India
Leerink initiates Zimmer Biomet stock coverage with Market Perform - Investing.com
The Bull Case For Zimmer Biomet (ZBH) Could Change Following First Outpatient Robotic Shoulder Replacement - Sahm
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer - Florida Hospital News and Healthcare Report
Wall Street Zen Upgrades Zimmer Biomet (NYSE:ZBH) to Buy - MarketBeat
Zimmer Biomet’s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
SNDL vs. Zimmer Biomet: A Financial Comparison - National Today
Douglas Lane & Associates LLC Raises Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Comerica Bank Lifts Stake in Zimmer Biomet Holdings, Inc. (ZBH) Amid Robotics Drive - MSN
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results - BioSpace
Zimmer Biomet (ZBH) Valuation Check After Mixed Returns And Robotics Growth Plans - Sahm
Zimmer Biomet (ZBH) Valuation Check After New Technology Leadership And Robotic Shoulder Surgery Milestones - Yahoo Finance
Zimmer Biomet Holdings, Inc. (ZBH) stock price, news, quote and history - Yahoo Finance UK
Zimmer Biomet Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch
Goldman Sachs Adjusts Zimmer Biomet Price Target to $89 From $88, Maintains Sell Rating - Moomoo
Oak Thistle LLC Grows Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Sivik Global Healthcare LLC's Zimmer Biomet Holdings Inc(ZBH) Holding History - GuruFocus
Zimmer Biomet Holdings, Inc. Appoints Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer, Effective April 14, 2026 - marketscreener.com
Zimmer Biomet (ZBH) Appoints New Leader for Science and Technolo - GuruFocus
Zimmer hires chief science, technology and medical affairs officer - Yahoo Finance
Fitch Affirms Zimmer Biomet at 'BBB'; Outlook Stable - marketscreener.com
Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Zimmer Biomet (NYSE: ZBH) exec vests 6,626 RSUs; 1,677 shares withheld - Stock Titan
Q3 2025 Zimmer Biomet Holdings Inc Earnings Call Transcript - GuruFocus
Zimmer Biomet (NYSE: ZBH) director adds 182 phantom stock units to deferred holdings - Stock Titan
Zimmer Biomet (NYSE: ZBH) director awarded new phantom stock units - Stock Titan
Zimmer Biomet (ZBH) director Louis Shapiro granted 154 Phantom Stock Units - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives new phantom stock unit grant - Stock Titan
Zimmer Biomet (NYSE: ZBH) director adds phantom stock units award - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives 154 Phantom Stock Units in deferred award - Stock Titan
Zimmer Biomet (NYSE: ZBH) director adds phantom stock units in deferred award - stocktitan.net
Zimmer Biomet (ZBH) director receives phantom stock unit award as deferred pay - Stock Titan
Matrix Asset Advisors Inc. NY Sells 90,174 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Zimmer Biomet Holdings Inc-Aktie (ZBH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Winkler Lori | SVP and CHRO |
Mar 12 '26 |
Sale |
94.66 |
2,650 |
250,849 |
10,224 |
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):